Anthropic's IPO book is reported covered for 825 million shares, but its $1.5tn test is for 18 billion

Bloomberg and FT anonymous-source reports of demand give Anthropic pricing leverage, because the deal offers only 6.3% of shares outstanding. A $1.5tn valuation needs $83.27 a share on the filing's diluted count at the $74 midpoint, and billions more shares may become eligible for sale within months.

Anthropic's IPO book is reported covered several times over, but the deal offers only 825m shares against 18.01bn fully diluted. A $1.5tn valuation needs about $83.3 a share on that count, or $114.6 on the 13.09bn shares outstanding. CTOL's view: treat $1.5tn as a pricing-day scarcity result whose holding risk passes to later buyers.

Bloomberg, relayed by investingLive, said the book was covered several times over. Syz Group relayed an FT report from five people familiar that bankers expect to price above $78, toward $1.5tn or more, with a raise above $100bn. Both are anonymous-source reports. The S-1/A No. 2, filed 10 Nov, still sets $70 to $78, and no later amendment had been filed on 12 Nov. CNBC reported that people familiar say pricing is planned for 18 Nov, with first trade on Nasdaq as ANT on 19 Nov.

The filing lists 13,086,672,593 shares after the offering and placement. At $78 that is $1.021tn, and at $70 it is $916bn.

The S-1/A's Additional Adjustments table, built at the $74 midpoint, reaches a fully diluted count. It has 7,430,143,944 Class A shares and 7,804,580,273 Class N shares. Options on the treasury-stock method add 1,704,567,865 and restricted stock units add 1,073,701,297. The total is 18,012,993,379. At $78 that is $1,405,013,483,562, which reproduces CNBC's $1.405tn. Amazon's $6.203bn of convertible notes alone convert into 1,840,444,962 Class N shares, subject to an ownership cap Amazon has elected not to waive.

$1.5tn divided by 18,012,993,379 is $83.27, or 6.8% above $78. On the stated 13.09bn shares, the same $1.5tn needs $114.62. The $26.0bn placement is fixed in dollars and option dilution moves with price. The final count will therefore differ from the midpoint count, and $83.27 is an indicative hurdle.

At the $78 top, the values are $1.021tn on the stated count, $1.405tn fully diluted and $1.5tn for the reported target.

Anthropic's filed range top reaches $1.02 trillion or $1.4 trillion, depending on the share basis

At the top of the filed $70 to $78 range, Anthropic's implied equity value is about $1.021 trillion on the 13,086,672,593 shares stated in the S-1/A and $1.405 trillion on the fully diluted basis reported by CNBC. The $1.5 trillion target sits above both.

View data

Anthropic's filed range top reaches $1.02 trillion or $1.4 trillion, depending on the share basis — data table
Valuation basis	Implied equity value, trillions of dollars
Filed range top, stated share count	1.021
Filed range top, fully diluted (reported)	1.405
Reported $1.5tn target	1.5

Source: SEC S-1/A No. 2 (10 Nov 2026); CNBC (10 Nov 2026)The stated-count value is 13,086,672,593 shares times $78. The fully diluted value is the $1.405 trillion CNBC reported at the top of the range. The $1.5 trillion figure is the target reported by the Financial Times via Syz Group.

A 6.3% float gives Anthropic the leverage

The 825m offered shares are 6.30% of post-offering shares and 4.58% of the diluted count, on CTOL's arithmetic. In Jay Ritter's IPO statistics, the 2025 median float across 90 IPOs was 14.5%, the mean 17.1% and the 25th percentile 9.1%. Anthropic sits below the first quartile. CNBC says the deal targets about 20% retail participation against a usual 5% to 10%. The S-1/A says board members and affiliates indicated interest in up to $303m.

A book covered several times over for 825m shares shows appetite for a small allocation. It does not show demand at a higher price once more stock can trade. One investor told CNBC on 6 Nov that $1.5tn was "a stretch".

Ritter's 2020 to 2025 data give base rates: 29% of IPOs priced above range, 55% within and 16% below, with mean first-day gains of 51%, 21% and 6%. These are base rates, not odds for Anthropic.

Two comparables split. SpaceX priced at $135, opened near $150 and closed its first day at $160.95, up 19%, after being 4x oversubscribed per Bloomberg. Facebook priced at $38 after bankers raised size and price from a $28 to $35 range, then closed at $38.23. Neither is a valuation comparable for Anthropic.

A $100bn raise needs the option or $89.70

Anthropic sells 801,351,354 of the 825m shares, raising $62.5bn at $78. Selling stockholders add 23,648,646 shares, or $1.84bn, for $64.35bn in all. A $26.0bn Class N placement to Google, NVIDIA, AMD, Broadcom, Micron, Microsoft and TSMC Partners brings the total to $90.35bn.

With the full 123.75m-share option, the total at $78 is $100.0025bn. Without it, $100bn needs $89.70 a share. At $83.27 the total is about $94.7bn without the option. A $1.5tn valuation does not by itself mean a $100bn raise, and $100bn does not need a price above the range.

The filing estimates $84.6bn of net proceeds from the IPO and placement at the $74 midpoint, or $93.7bn with the full option. At the same midpoint the placement is 351,351,348 shares, restricted securities that the filing says carry no lock-up. Liquidity at 30 Sep, before proceeds, was $146.6bn: $95.6bn of cash, $36.3bn of short-term investments and $14.8bn of facility availability.

The price has to be earned, and analysts split on it

CNBC reported nine-month revenue of $33.24bn, against about $2.5bn a year earlier, and run-rate revenue of about $81bn at the end of October. On CTOL's arithmetic, $1.5tn is about 18.5 times that run rate, which is a point-in-time measure rather than recognised revenue. CNBC also reported a nine-month net loss of $104bn, including a $94.3bn non-cash fair-value charge, and an operating loss of $1.26bn.

Syz's illustration shows what $1.5tn asks. At 30 times earnings it needs $50bn of 2028 net income. At a 21% tax rate and a 35% pre-tax margin that is $181bn of revenue, or $253bn at 25%. Syz cites a 2028 plan of $190bn to $200bn, which on CTOL's arithmetic would need a pre-tax margin of about 33.3% to 31.6%. This is a sensitivity, not a forecast.

Analysts disagree. Morningstar's Malik Ahmed Khan sets fair value at $92.0 a share, or $1.7tn. His base case is five-year revenue growth of 47% (2027 to 2031), and his bear case is $25. Kyle Guske II of New Constructs wrote: "Make no mistake, we don’t think Anthropic should IPO at any price." D.A. Davidson's Gil Luria told CNBC on 6 Nov: "Investors will expect the IPO to be priced at least at the low end of previous expectations."

Supply arrives in stages after the book closes

The filing says up to 316m Class A shares held by non-founder directors, officers, employees and consultants may be sold from the first trading day. That equals 38% of the 825m offered. Up to 3.3bn more may become eligible before the 180-day expiry, including up to 1.7bn on the second trading day after fiscal 2026 results.

Co-founders and holders above 0.5% of fully diluted shares face 365 days. Eligibility is not selling. Control also stays concentrated. One Class F share held by an entity owned by the seven co-founders carries 50.1% of voting power on most matters. The Long-Term Benefit Trust elects a board majority, and Nasdaq treats Anthropic as a controlled company.

The next check is the 1.7bn tranche. It opens on the second trading day after fiscal 2026 results, which Syz's indicative schedule puts by May 2027. A close above $83.27, adjusted for the updated diluted count, once that stock is eligible would be evidence that the $1.5tn price survived more supply. Until then, the evidence favours treating $1.5tn as a scarcity price, with the holding risk on later buyers.